Back

Effect of dipeptidyl peptidase 4 inhibitor Sitagliptin against ischemia reperfusion injury in normolipidemic and hyperlipidemic rat models

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Signal transduction in ischemic heart disease Ischaemia, Infarction, Cardioprotection ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Amin Al-Awar

University of Szeged, Szeged (Hungary)

8 More presentations in this session

Presentation thumbnail
Professor X. Wang (Melbourne, AU)
Abstract
Presentation thumbnail
Ms P. Ortiz Sanchez (Madrid, ES)
Abstract
Presentation thumbnail
Associate Professor H. Pan (Saint Louis, US)
Abstract Slides
Presentation thumbnail
Doctor J. Winter (Berlin, DE)
Abstract
Presentation thumbnail
Mr S. Bokredenghel (Cologne, DE)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Signal transduction in ischemic heart disease

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
27 August 2021
thumbnail
Congress Presentation
Mitochondrial succinate transport as a novel therapeutic target for cardiac ischemia/reperfusion injury
28 August 2023
thumbnail
Webinar
Diabetes and ACS - enhancing post-discharge outcomes after primary PCI
26 May 2025
thumbnail
Congress Presentation
Modulation of myocardial resistance to ischemic and reperfusion injury through changes in the cytokine profile using probiotics in experiment
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources